Public Safety - Elevator Inspection Certificates - Searchable Database
HB0553 requires the Maryland Medical Assistance Program (Medicaid) to cover self-measured blood pressure monitoring for eligible recipients beginning January 1, 2026. The bill defines eligible recipients to include people who are pregnant, postpartum, or diagnosed with chronic kidney disease, diabetes, heart disease, or a cardiometabolic disease. Coverage must include validated home blood pressure monitors and reimbursement for provider and staff time related to patient training, data transmission, interpretation of readings, remote patient monitoring, and related educational co-interventions.
The bill also directs the Program to develop and implement an education campaign to inform eligible recipients and health care providers about the benefits and use of blood pressure monitoring technology, including help with setup and troubleshooting. Beginning in 2027, the Department must submit annual reports to legislative committees on the number of recipients served, outcomes associated with monitor use, and any cost savings achieved. The act takes effect July 1, 2025, with coverage beginning later on January 1, 2026.
This law amends the Health - General Article to add a new Medicaid coverage mandate for self-measured blood pressure monitoring and related services. It expands the Maryland Medical Assistance Program’s covered benefits for a defined set of high-risk patients and requires administrative, educational, and reporting functions by the Department. The bill may affect Medicaid recipients, health care providers, community health workers, and vendors of validated home blood pressure monitors, while remaining subject to state budget limits and federal law.
The available record shows no committee transcript or recorded votes indicating opposition or debate, so the bill appears to have moved without documented controversy in the provided materials. The policy direction is generally supportive of maternal health and chronic disease management, with an emphasis on prevention, home monitoring, and care coordination. The absence of recorded dissent suggests the measure was broadly acceptable or noncontroversial in the available legislative history.
No specific points of contention are documented in the provided transcripts or vote history. Potential issues inherent in the bill include the fiscal impact on Medicaid, the administrative burden of implementing coverage and reporting, and questions about how broadly to interpret eligible conditions such as cardiometabolic disease. Another possible area of discussion is whether the required education campaign and reimbursement for remote monitoring services are sufficient to ensure effective uptake and equitable access.